Comparative effectiveness between two types of head-mounted magnification modes using a smartphone-based virtual display. Wilmer
A double blind, placebo-controlled, pilot investigation of an anti-seizure medication in the treatment of psychosis in subjects with dementia.
A phase 3, randomized, double-blind, active controlled, multi-center trial to evaluate the safety and efficacy of a novel dual PPAR alpha/gamma agonist compared to a TSD in subjects with type 2 diabetes who have inadequate glycemic control.
A randomized, double blind, placebo-controlled study to explore the efficacy and safety of a atypical antipsychotic, long acting intra-muscular injectible in the prevention of mood episodes in bipolar I disorder, with open-label extension.
A randomized, double blind, placebo-controlled, parallel group, dose-response study to evaluate the efficacy and safety of 3 fixed doses of a novel atypical antipsychotic agent in subjects with schizophrenia.
An open-label, parallel, randomized study to explore the in vitro / in vivo correlation of a novel atypical antipsychotic long-acting formulations and the comparability of two different formulations of varying particle size in subjects with schizophrenia.
A randomized, double blind, placebo-controlled evaluation of the safety and efficacy of a triptan nasal spray in patients with moderate to severe migraine headache.
A randomized, double blind, placebo-controlled evaluation of the safety and efficacy of a glutamate receptor antagonist in patients with mild to moderate dementia of Alzheimer’s Type.
A randomized, placebo-controlled, double blind study to evaluate acetaminophen in the acute and pre-emptive treatment of headaches associated with Aggrenox.
